Cognizant Technology Solutions Corp
Cognizant Technology Solutions Corp (CTSH) Implied Volatility Current
CTSH's 30 day implied volatility is 45.06%, with an IV Rank of 53.17%. This is an average IV Rank versus the past year, meaning Cognizant Technology Solutions Corp options are fairly priced and currently offer no clear edge to buyers or sellers. CTSH's 30 day historical volatility sits at 48.05%, which means implied volatility is running 2.99 points below historical volatility, as of Nov 5, 2026.
Read more
Tracking CTSH implied volatility helps you spot when Cognizant Technology Solutions Corp options are historically cheap or expensive, and where the best trades are hiding. When CTSH IV rises, premiums increase and sellers get more attractive pricing, and when it drops, buyers find cheaper contracts. Use our scanner to monitor CTSH implied volatility current levels in real time and filter for high probability trades.
Implied volatility is derived from option prices and represents the annualized expected move of a stock. Tracking CTSH IV rank helps you see whether CTSH's implied volatility is historically high or low, since IV rank compares today's reading against the past year's range. A high rank signals relatively expensive premiums and tends to favor sellers, a low rank signals relatively cheap premiums and tends to favor buyers.
Cognizant Technology Solutions Corporation, a professional services company, provides consulting and technology, and outsourcing services in North America, Europe, and internationally. It operates through four segments: Financial Services; Healthcare; Products and Resources; and Communications, Media and Technology. The company offers customer experience enhancement, robotic process automation, analytics, and AI services in areas, such as digital lending, fraud detection, and next generation payments; the shift towards consumerism, outcome-based contracting, digital health, delivering integrated seamless, omni-channel, and patient-centered experience; and services that drive operational improvements in areas, such as clinical development, pharmacovigilance, and manufacturing, as well as claims processing, enrollment, membership, and billing to healthcare providers and payers, and life sciences companies, including pharmaceutical, biotech, and medical device companies.
Implied Volatility
IV is slightly elevated. Premiums are richer, leaning toward sellers.
As of Nov 5, 2026
Prices move. This one stays.Lock in 5 years at a special price and save $2,243. Ending soon.See the Early Bird Black Friday deal →